Back

Shared and disease-specific human brain vascular signatures in Alzheimer's disease, frontotemporal dementia, and Huntington's disease

Forster, P. M.; Bracko, O.; Rust, R.

2026-07-03 neuroscience
10.64898/2026.07.01.735865 bioRxiv
Show abstract

The blood-brain barrier (BBB) plays a central role in brain function and is increasingly implicated in neurodegenerative disease. Major neurodegenerative disorders, including Alzheimer's disease (AD), frontotemporal dementia (FTD), and Huntington's disease (HD), share overlapping pathological features. Yet, the extent to which these diseases converge or diverge at the level of BBB-associated cell types remains poorly understood. Here, we performed a comparative analysis of vessel-enriched human brain transcriptomic datasets across AD, FTD, and HD to define shared and disease-specific neurovascular alterations. We identify a partially conserved transcriptional signature of vascular dysfunction across all three diseases, alongside disease-specific changes in endothelial, pericyte, and perivascular cell populations. Endothelial remodeling was most prominent in capillary and venous segments, highlighting segment-specific vulnerability along the arteriovenous axis. Notably, we identified two molecularly distinct human pericyte subtypes across all three datasets and found a consistent reduction in the matrix-type pericytes (M-peri) fraction, suggesting a selective decline. Cell-cell communication analysis further revealed reorganized endothelial-pericyte signaling networks, with prominent alterations in extracellular matrix-associated pathways, including LAMININ, COLLAGEN, FN1, and NCAM, together with changes in contact-dependent and vascular signaling pathways such as NOTCH and VEGF. Together, our findings define shared and disease-specific neurovascular mechanisms across major neurodegenerative disorders and highlight BBB-associated pathways as central features of neurodegeneration, providing a framework for future diagnostic and therapeutic strategies.

Matching journals

The top 11 journals account for 50% of the predicted probability mass.

1
Acta Neuropathologica
58 papers in training set
Top 0.1%
9.6%
2
Nature Communications
5641 papers in training set
Top 24%
6.6%
3
Acta Neuropathologica Communications
89 papers in training set
Top 0.3%
6.6%
4
Molecular Psychiatry
282 papers in training set
Top 1%
4.8%
5
Fluids and Barriers of the CNS
28 papers in training set
Top 0.1%
4.3%
6
Advanced Science
286 papers in training set
Top 2%
4.3%
7
EMBO Molecular Medicine
95 papers in training set
Top 0.2%
4.0%
8
Brain
168 papers in training set
Top 1%
3.2%
9
Alzheimer's & Dementia
163 papers in training set
Top 1%
3.2%
10
Cell Reports
1498 papers in training set
Top 13%
3.1%
11
Neurobiology of Disease
148 papers in training set
Top 1%
2.7%
50% of probability mass above
12
JCI Insight
277 papers in training set
Top 3%
2.6%
13
Molecular Neurodegeneration
55 papers in training set
Top 0.8%
2.4%
14
Cell Death & Disease
21 papers in training set
Top 0.2%
2.1%
15
Proceedings of the National Academy of Sciences
2444 papers in training set
Top 24%
2.1%
16
Journal of Neuroinflammation
61 papers in training set
Top 0.7%
1.9%
17
Communications Biology
993 papers in training set
Top 14%
1.7%
18
Scientific Reports
3612 papers in training set
Top 55%
1.7%
19
Glia
81 papers in training set
Top 0.8%
1.7%
20
Journal of Biomedical Science
17 papers in training set
Top 0.1%
1.7%
21
International Journal of Molecular Sciences
494 papers in training set
Top 8%
1.7%
22
Neuron
337 papers in training set
Top 4%
1.5%
23
Alzheimer's Research & Therapy
57 papers in training set
Top 0.9%
1.4%
24
eBioMedicine
183 papers in training set
Top 4%
1.1%
25
eLife
5828 papers in training set
Top 58%
1.1%
26
Nature Neuroscience
252 papers in training set
Top 4%
1.1%
27
PLOS ONE
5266 papers in training set
Top 59%
1.0%
28
The Journal of Neuroscience
1025 papers in training set
Top 9%
0.9%
29
Alzheimer's & Dementia
14 papers in training set
Top 0.3%
0.8%
30
Science Advances
1243 papers in training set
Top 31%
0.8%